Caris Life Sciences Inc(US:CAI) Zhi Tong Cai Jing·2025-06-17 07:09Group 1 - Caris Life Sciences announced an increase in the price range for its upcoming IPO to $19 to $20 per share, aiming to raise a total of $459 million [1][2] - The company plans to issue 23.5 million shares, with insiders intending to purchase $75 million worth of shares, representing 16% of the offering [1] - The revised fundraising amount is expected to be 15% higher than the original estimate [1] Group 2 - Founded in 2008, Caris Life Sciences reported revenue of $452 million for the 12 months ending March 31, 2025 [2] - The company is set to list on NASDAQ under the ticker symbol "CAI" [2] - The IPO is being managed by a consortium of banks including Bank of America Securities, JPMorgan, Goldman Sachs, Citigroup, TD Cowen, Evercore ISI, and Guggenheim Securities, with pricing expected to occur during the week of June 16, 2025 [2]